ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 94 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $282,000 | -37.2% | 20,470 | -27.6% | 0.00% | – |
| Q1 2022 | $449,000 | -46.6% | 28,270 | -25.9% | 0.00% | -100.0% |
| Q4 2021 | $841,000 | -45.8% | 38,132 | -26.5% | 0.00% | 0.0% |
| Q3 2021 | $1,551,000 | -32.2% | 51,907 | +0.5% | 0.00% | -50.0% |
| Q2 2021 | $2,286,000 | -52.2% | 51,632 | -52.1% | 0.00% | -60.0% |
| Q1 2021 | $4,784,000 | +3.4% | 107,826 | +27.8% | 0.01% | 0.0% |
| Q4 2020 | $4,627,000 | +139.2% | 84,377 | -0.3% | 0.01% | +150.0% |
| Q3 2020 | $1,934,000 | -0.8% | 84,636 | -9.1% | 0.00% | 0.0% |
| Q2 2020 | $1,949,000 | +121.0% | 93,123 | +47.2% | 0.00% | +100.0% |
| Q1 2020 | $882,000 | -25.1% | 63,250 | +22.1% | 0.00% | 0.0% |
| Q4 2019 | $1,178,000 | +13.2% | 51,788 | -42.0% | 0.00% | 0.0% |
| Q3 2019 | $1,041,000 | – | 89,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |